389 related articles for article (PubMed ID: 27327442)
1. Major surfome and secretome profile of Streptococcus agalactiae from Nile tilapia (Oreochromis niloticus): Insight into vaccine development.
Li W; Wang HQ; He RZ; Li YW; Su YL; Li AX
Fish Shellfish Immunol; 2016 Aug; 55():737-46. PubMed ID: 27327442
[TBL] [Abstract][Full Text] [Related]
2. GroEL, a novel vaccine candidate of piscine Streptococcus agalactiae identified by immunoproteome.
Li W; Li Y; Hu YZ; Mo XB; Xu GH; Xie LW; Li AX
Fish Shellfish Immunol; 2019 Jan; 84():377-383. PubMed ID: 30308296
[TBL] [Abstract][Full Text] [Related]
3. GapA, a potential vaccine candidate antigen against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus).
Zhang Z; Yu A; Lan J; Zhang H; Hu M; Cheng J; Zhao L; Lin L; Wei S
Fish Shellfish Immunol; 2017 Apr; 63():255-260. PubMed ID: 28219739
[TBL] [Abstract][Full Text] [Related]
4. Development of Streptococcus agalactiae vaccines for tilapia.
Liu G; Zhu J; Chen K; Gao T; Yao H; Liu Y; Zhang W; Lu C
Dis Aquat Organ; 2016 Dec; 122(2):163-170. PubMed ID: 28000606
[TBL] [Abstract][Full Text] [Related]
5. Characterization of novel antigenic vaccine candidates for nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae infection.
Ma Y; Hao L; Liang Z; Ma J; Ke H; Kang H; Yang H; Wu J; Feng G; Liu Z
Fish Shellfish Immunol; 2020 Oct; 105():405-414. PubMed ID: 32712231
[TBL] [Abstract][Full Text] [Related]
6. Comparative proteome analysis of two Streptococcus agalactiae strains from cultured tilapia with different virulence.
Li W; Su YL; Mai YZ; Li YW; Mo ZQ; Li AX
Vet Microbiol; 2014 May; 170(1-2):135-43. PubMed ID: 24594355
[TBL] [Abstract][Full Text] [Related]
7. Phosphoglycerate kinase enhanced immunity of the whole cell of Streptococcus agalactiae in tilapia, Oreochromis niloticus.
Wang YT; Huang HY; Tsai MA; Wang PC; Jiang BH; Chen SC
Fish Shellfish Immunol; 2014 Dec; 41(2):250-9. PubMed ID: 25218275
[TBL] [Abstract][Full Text] [Related]
8. An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus).
Zhang D; Gao Y; Li Q; Ke X; Liu Z; Lu M; Shi C
Fish Shellfish Immunol; 2020 Mar; 98():853-859. PubMed ID: 31751658
[TBL] [Abstract][Full Text] [Related]
9. Development of a vaccine against Streptococcus agalactiae in fish based on truncated cell wall surface anchor proteins.
Liu H; Zhang S; Shen Z; Ren G; Liu L; Ma Y; Zhang Y; Wang W
Vet Rec; 2016 Oct; 179(14):359. PubMed ID: 27660279
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of live attenuated vaccine derived from the Streptococcus agalactiae on the immune responses of Oreochromis niloticus.
Laith AA; Abdullah MA; Nurhafizah WWI; Hussein HA; Aya J; Effendy AWM; Najiah M
Fish Shellfish Immunol; 2019 Jul; 90():235-243. PubMed ID: 31009810
[TBL] [Abstract][Full Text] [Related]
11. Duration of protective antibodies and correlation with survival in Nile tilapia Oreochromis niloticus following Streptococcus agalactiae vaccination.
Pasnik DJ; Evans JJ; Klesius PH
Dis Aquat Organ; 2005 Sep; 66(2):129-34. PubMed ID: 16231638
[TBL] [Abstract][Full Text] [Related]
12. Development of live attenuated Streptococcus agalactiae as potential vaccines by selecting for resistance to sparfloxacin.
Pridgeon JW; Klesius PH
Vaccine; 2013 May; 31(24):2705-12. PubMed ID: 23583891
[TBL] [Abstract][Full Text] [Related]
13. Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines.
Wang Q; Fu T; Li X; Luo Q; Huang J; Sun Y; Wang X
Fish Shellfish Immunol; 2020 Feb; 97():382-389. PubMed ID: 31841691
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration.
Evans JJ; Klesius PH; Shoemaker CA
Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of two adjuvants administrated with a novel hydrogen peroxide-inactivated vaccine against Streptococcus agalactiae in Nile tilapia fingerlings.
Ramos-Espinoza FC; Cueva-Quiroz VA; Yunis-Aguinaga J; Alvarez-Rubio NC; Paganoti de Mello N; Engrácia de Moraes JR
Fish Shellfish Immunol; 2020 Oct; 105():350-358. PubMed ID: 32717322
[TBL] [Abstract][Full Text] [Related]
16. Vaccine-induced antibody level as the parameter of the influence of environmental salinity on vaccine efficacy in Nile tilapia.
Wang J; He RZ; Lu GL; Luo HL; Lu DQ; Li AX
Fish Shellfish Immunol; 2018 Nov; 82():522-530. PubMed ID: 30118846
[TBL] [Abstract][Full Text] [Related]
17. Development of attenuated erythromycin-resistant Streptococcus agalactiae vaccine for tilapia (Oreochromis niloticus) culture.
Liu L; Lu DQ; Xu J; Luo HL; Li AX
J Fish Dis; 2019 May; 42(5):693-701. PubMed ID: 30893488
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy of cationic-PLGA microspheres loaded with DNA vaccine encoding the sip gene of Streptococcus agalactiae in tilapia.
Ma YP; Ke H; Liang ZL; Ma JY; Hao L; Liu ZX
Fish Shellfish Immunol; 2017 Jul; 66():345-353. PubMed ID: 28476676
[TBL] [Abstract][Full Text] [Related]
19. Immune response and protective efficacy of two new adjuvants, Montanide™ ISA 763B VG and Montanide™ GEL02, administered with a Streptococcus agalactiae ghost vaccine in Nile tilapia (Oreochromis niloticus).
Wangkaghart E; Deville S; Wang B; Srisapoome P; Wang T; Secombes CJ
Fish Shellfish Immunol; 2021 Sep; 116():19-29. PubMed ID: 34153428
[TBL] [Abstract][Full Text] [Related]
20. Immunoproteomic analysis of the antibody response obtained in Nile tilapia following vaccination with a Streptococcus iniae vaccine.
LaFrentz BR; Shoemaker CA; Klesius PH
Vet Microbiol; 2011 Sep; 152(3-4):346-52. PubMed ID: 21601381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
